Skip to main contentAll experts

DrDavid Nelson

PROF

MD-MEDICINE

Orcid identifier0000-0001-6344-8548 (opens in a new tab)⁠
  • PROF
    MD-MEDICINE

GRANTS

  • GRANT
    CURE-HCV: Community-Based Uptake of Rapid Evaluation and HCV Treatment
    Substance Abuse Mental Health Ser Admin24 Sep 2025 - 29 Sep 2027
    Active
  • GRANT
    Assessing performance of a Hepatitis C Emergency Department (HepC-END) Screening Tool
    National Institute of Health Nida8 Sep 2023 - 31 Jul 2028
    Active
  • GRANT
    Capacity Building Projects to Support UF Health's Participation in the Health Systems Implementation Initiative
    Patient-Centered Outcomes Research Institute18 Jul 2023 - 31 Dec 2024
    Expired
  • GRANT
    Medicaid Prior Authorization Policies for Chronic Hepatitis C Treatment in Vulnerable Populations
    National Institute of Health Nida17 Apr 2018 - 30 Apr 2023
    Expired
  • GRANT
    Stakeholder Engagement and Multi-Risk Assessment in Dental Care Settings
    National Institute of Health Nidcr1 Apr 2018 - 31 Oct 2018
    Expired
  • GRANT
    Together: Transforming and Translating Discovery to Improve Health
    National Institute of Health Ncats1 Apr 2018 - 1 Jul 2019
    Expired
  • GRANT
    Safety of Direct Acting Antiviral Medications for Hepatitis C
    Patient-Centered Outcomes Research Institute1 Mar 2018 - 31 Oct 2018
    Expired
  • GRANT
    The National Dental PBRN FY18
    National Institute of Health Nidcr29 Aug 2017 - 31 Mar 2018
    Expired
  • GRANT
    A Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir/Pibrentasvir (G/P) +/- Ribavirin for GT1 Subjects with Chronic Hepatitis C Previously Treated with an NS5A Inhibitor + Sofosbuvir Therapy
    Abbvie13 Apr 2017 - 22 Oct 2018
    Expired
  • GRANT
    COM CTSI Institutional Matching Support Year 3-4
    Florida Clinical Practice Association1 Apr 2017 - 30 Jun 2020
    Expired
  • GRANT
    Together: Transforming and Translating Discovery to Improve Health
    National Institute of Health Ncats1 Apr 2017 - 31 Mar 2018
    Expired
  • GRANT
    A Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir/Pibrentasvir (G/P) +/- Ribavirin for GT1 Subjects with Chronic Hepatitis C Previously Treated with an NS5A Inhibitor + Sofosbuvir Therapy
    Abbvie28 Mar 2017 - 19 Mar 2021
    Expired
  • GRANT
    The Patient-Reported Outcomes Project of HCV-TARGET (PROP up TARGET)
    Patient-Centered Outcomes Research Institute31 Aug 2016 - 31 Jul 2017
    Expired
  • GRANT
    THE PRIORITIZE STUDY: A PRAGMATIC, RANDOMIZED STUDY OF ORAL REGIMENS FOR HEPATITIS C: TRANSFORMING DECISION-MAKING FOR..
    Patient-Centered Outcomes Research Institute23 May 2016 - 11 Jul 2023
    Closed
  • GRANT
    Collaborating to Advance Teaching and Learning of Science Educators and Students (CATALySES)
    National Institute of Health Nigms4 May 2016 - 30 Jun 2023
    Expired
  • GRANT
    TOGETHER: TRANSFORMING AND TRANSLATING DISCOVERY TO IMPROVE HEALTH ,
    National Institute of Health Ncats4 Apr 2016 - 31 Mar 2017
    Expired
  • GRANT
    Prioritize Study
    Patient-Centered Outcomes Research Institute10 Mar 2016 - 31 Mar 2022
    Expired
  • GRANT
    A single arm, open label study to evaluate the efficacy and satety of ABT-493/ABT-530 in adults with chronic hepatitis C virus genotype 1,2,4,5 or 6 infection and compensated Cirrhosis
    Abbvie15 Feb 2016 - 24 Feb 2018
    Expired
  • GRANT
    An Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Low-Dose Ribavirin QD in Subjects with Genotype 1a Chronic Hepatitis C Virus Infection (GEODE II)
    Abbvie12 Jan 2016 - 18 Sep 2018
    Expired
  • GRANT
    Patient Reported Outcomes Project of HCV-Target (Prop up TARGET)
    Patient-Centered Outcomes Research Institute11 Jan 2016 - 31 Jul 2018
    Expired
  • GRANT
    A SINGLE ARM OPEN LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABT-493/ABT-530 IN RENALLY IMPAIRED ADULTS WITH...
    Abbvie17 Dec 2015 - 16 Dec 2018
    Closed
  • GRANT
    A Registry for Subjects with Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment with a Sofosbuvir-Based Regimen without Interferon for Chronic Hepatitis C Infection in Gilead-Sponsored Trials"
    Gilead Sciences2 Sep 2015 - 16 Jun 2023
    Expired
  • GRANT
    Comparing Oral Medicines to Treat Hepatitis C Virus -- The PRIORITIZE Study (opens in a new tab)⁠
    Patient-Centered Outcomes Research Institute1 Sep 2015 - 31 Mar 2022
    People funded by this grant:
    • Nelson DR
    MORELEARN MORE (opens in a new tab)
  • GRANT
    Evaluation of Baseline HCV Resistance mutations in Genotype1 patients initiating tretamnent in real-world settings
    Janssen Services31 Aug 2015 - 21 Dec 2016
    Expired
  • GRANT
    Together: Transforming and Translating Discovery to Improve Health
    National Institute of Health Ncats20 Aug 2015 - 31 Mar 2016
    Expired